ClinicalTrials.gov
public full text
Public Domain
TB006 for Autism Spectrum Disorder
Multisite 14-week prospective double-blind placebo controlled parallel-group randomized clinical trial with 14-week open-label extension at the end of double-blind treatment phase for placebo subjects. Eligible subjects will be randomized within each site in 2:1 ratio to receive either TB006 or placebo treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Trial Evaluating the Effects of Ganaxolone in Children With Autism#872712
- Effects of Cathodal tDCS on Executive Functions in Autism#1172976
- Artificial intelligence-supported therapeutic interventions for autism spectrum disorder: a systematic review.#796634
- A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder#1008905
- Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial#901869
Record · ID 1008933
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive